About Luxir and Luxir+
KIMERA® LABS OFFERS OPTIMAL PURITY.
Kimera Labs is the leading exosome biotechnology laboratory specializing in the production of perinatal mesenchymal stem cell-derived (MSC) exosome products.
is a topical solution specially developed for skin care purposes. The product contains proteins, enzymes, growth factors, and exosomes derived from mesenchymal stem cells (MSCs). The MSC cell bank utilized in our manufacturing process is meticulously isolated from a single donated pre-COVID human placenta, following strict regulatory guidelines.
is unique. Based on its unmatched RNA content, the potency of our formula creates outcomes unseen by others. When combined with complementary treatments, the results are superior. Enhance the beauty of your skin with the power of Luxir.
THERE IS NO EQUAL.
- Luxir has 5 trillion microvesicles and Luxir+ has 15 trillion microvesicles containing Biologically Active Exosomes
- The only Exosome products containing RNA – according to fluorescence signal detectable in an RNA quantification assay
- The only commercially available MSC Exosome
- Produced from a master MSC cell bank from a pre-Covid, single donor, placental source
- With High Potency Amino Acids
Fortified With SKIN ENHANCING Benefits of Amino Acids
QUALITY
INNOVATION
Kimera Labs is a leading exosome biotechnology laboratory specializing in the production of perinatal mesenchymal stem cell-derived (MSC) exosome products. Founded in 2012 by Duncan Ross, Ph.D., Kimera Labs has been the leader in the field of MSC exosome production and isolation. Unlike biologic tissue laboratories that manufacture exosome products by direct processing of donor tissues such as adult bone marrow or placenta, Kimera Labs produces MSC exosomes from isolated mesenchymal stem cell cultures using chemically defined media, which contain no animal or human serum. Using advanced, proprietary, exosome isolation technology, Kimera produces the highest-purity MSC exosomes.
EDUCATION
REGULATION
Our Chief Medical Officer
Dr. Halim’s is a Board certified Anesthesiologist as well as Aesthetic Medicine, Anti-aging and Regenerative Medicine Physician. Dr. Halim’s medical training began at Northwestern University in Chicago.
She pursued her interests in Aesthetics, Lasers, PDO Threads thereby continued to build her expertise in various areas such as facial rejuvenation, integrative/functional medicine, nutrition, and hyperbaric medicine so that she may combine this knowledge to achieve beauty from inside out with the focus being on each patient’s skincare, diet, fitness as well as lifestyle.
Dr. Halim has successfully held many roles as National Medical Director for hospital, surgical and aesthetic practice startups as part of a large Healthcare company. She runs a Medical Consulting Company, is a national speaker and educator, has been a KOL for various companies as well speaker for A4M, Boston Biolife, and CMO for Empire Medical as well as CMO for Kimera Labs.
Dr. Halim has been featured in Buzzfeed for her trademarked treatment of cellulite combining Carboxytherapy and PDO threads, also has presented at the Aesthetics Everything, the Global Aesthetics Conference and the Global Virtual Aesthetics Summit, The Aesthetic Show, Miami Cosmetic Surgery, to name a few. She has also been featured in several editorials and magazines for her expertise in beauty, wellness and skincare such as Vogue, Glamour, HuffPost, OprahDaily, GQ, Byrdie and many more.
Azza Halim, MD currently practices in Florida and Chicago as well as Newport Beach, California.
IG: Azzamdbeauty
Web: azzamdbeauty.com
Azza Halim, MD
AN INVESTIGATIONAL PILOT STUDY
Forty patients were enrolled in a randomized, double-blinded, placebo (saline) controlled study. There were 20 patients in the treatment group and 20 patients in the saline control group. Each group underwent facial microneedling with immediate topical application of either 5 billion exosomes suspended in saline, or saline alone. Treatments were repeated at 30, 60, and 90 days, with final analysis at 120 days. Standardized photography was coupled with 3-dimensional analysis utilizing the Quantificare Imaging System. Linear analog tests were also administered to objectify patient satisfaction.
There were no adverse reactions, allergic, or hypersensitivity reactions reported. The exosome treatment group showed improved tone, quality, and clarity of their skin compared to the control group (p < .0001), with a reduction in pores, pigment, oiliness, and improvement in evenness of skin. There was a constant progression of satisfaction with results in the treatment group from 30 to 120 days, compared with a high degree of dissatisfaction with results in the control group.
Find out more about what Luxir and Luxir+ can do for your patients and your practice.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to text, graphics, images, and other material contained on this website, are for informational purposes only. No material on this site is intended to substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking a new health care regimen. Never disregard professional medical advice or delay seeking it because of something you have read on this website.